ENTA SCHEDULE 13G/A: SEC filing

Farallon Capital Management and affiliated individuals

Filed with the SEC on Aug 14, 2026 · accession 0000908834-26-000416

ENTA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. Farallon Capital Management and affiliated individuals filed a joint acquisition statement (Amendment to Schedule 13G) regarding their passive ownership position in Enanta Pharmaceuticals. The stock moved -2.1% by the first close after the filing.

Summary of the filing

Farallon Capital Management and affiliated individuals filed a joint acquisition statement (Amendment to Schedule 13G) regarding their passive ownership position in Enanta Pharmaceuticals. The filing is a routine administrative amendment with no change in investment intent disclosed.

For details, click here →

Key details

Reporting person / filerFarallon Capital Management, L.L.C.

Issuer of securities ownedEnanta Pharmaceuticals, Inc.

Managing member, farallon capital management, l.l.c.Hannah E. Dunn

Reporting person (attorney-in-fact)Joshua J. Dapice

Reporting person (attorney-in-fact)Philip D. Dreyfuss

Reporting person (attorney-in-fact)Varun N. Gehani

Reporting person (attorney-in-fact)Nicolas Giauque

Reporting person (attorney-in-fact)Avner A. Husen

Reporting person (attorney-in-fact)David T. Kim

Reporting person (attorney-in-fact)Michael G. Linn

Reporting person (attorney-in-fact)Patrick (Cheng) Luo

Reporting person (attorney-in-fact)Thomas G. Roberts, Jr.

Reporting person (attorney-in-fact)Edric C. Saito

Reporting person (attorney-in-fact)Daniel S. Short

Reporting person (attorney-in-fact)Andrew J. M. Spokes

Reporting person (attorney-in-fact)John R. Warren

Reporting person (attorney-in-fact)Mark C. Wehrly

How ENTA stock reacted

Close before

$13.44

Aug 13, 2026

First close after

-2.08%

$13.16

5 trading days

-2.31%

$13.13

Since filing

-18.15%

$11.00

✦ Ask GOAX AI about this filing — what it means for ENTA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ENTA?

Click here

Frequently asked questions

What did ENTA file with the SEC on Aug 14, 2026?

ENTA filed a SCHEDULE 13G/A (SEC filing). Farallon Capital Management and affiliated individuals filed a joint acquisition statement (Amendment to Schedule 13G) regarding their passive ownership position in Enanta Pharmaceuticals. The filing is a routine administrative amendment with no change in investment intent disclosed.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ENTA stock react to this filing?

ENTA closed at $13.44 before the filing and $13.16 on Aug 14, 2026 (-2.08%). Five trading days later: $13.13 (-2.31%).

Other ENTA SEC filings

Get alerts when ENTA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ENTA overview ENTA analysis ENTA news Latest SEC filings